Women with pre-existing hypertension may continue their current antihypertensive medication, while angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitors are, contraindicated due to adverse fetal and neonatal outcomes. This evidence concerns the gene ACE and hypertensive disorder.